SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...
Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone